President Museveni of Uganda and Deputy President Ruto of Kenya visited the DEI Biopharma manufacturing facility and met with the technical teams from Spain, Italy, Sweden, and the USA to provide details about their role in the project which intends to produce biotechnology products such as mRNA vaccines, biosimilars, gene, and cell therapy products alongside traditional pharmaceutical products to make Uganda self-sufficient in the healthcare field. Established on a 100-acre campus containing muliple manufacturing facilities making DEI Biopharma as the largest in Africa and the only company producing biological products including mRNA vaccines. They toured the facility, along with the Minister of Science, Technology and Innovation, Dr. Monica Musenero, who assured full support of the Uganda and Kenya governments to expedite the completion of DEI Biopharma.
President Mr. Mirco Pellacan from Italy and the BIORE team led by Dr. Lluis Adella from Spain are now completing a 16,000 square meter facility for many lifesaving products manufactured in Uganda and assured that the products manufactured by DEI Pharma will meet all global standards of quality.
This project will generate thousands of new high-paying jobs, provide every pharmaceutical and biopharmaceutical product needs of Ugandans and for the rest of the citizens of Africa, a role model operation that will earn billions of dollars of foreign exchange for Uganda.